PPARγ modulators

Details PPARγ modulators PPARγ modulators

2002-04-15

2008-10-21

Andres, Janet L. (Department: 1625)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S252130, C514S309000, C514S361000, C514S362000, C514S363000, C514S369000, C514S398000, C514S407000, C544S238000, C544S239000, C544S358000, C546S141000, C546S146000, C546S147000, C546S148000, C548S127000, C548S128000, C548S129000, C548S130000, C548S131000, C548S132000, C548S133000, C548S134000, C548S135000, C548S136000, C548S143000, C548S144000, C548S316400, C548S324100, C548S324500, C548S325100, C548S366100, C548S366700, C548S367100, C548S370100, C568S370000

Reexamination Certificate

active

07439242

ABSTRACT:
Modulators of PPARγ activity are provided which are useful in pharmaceutical compositions and methods for the treatment of conditions such as type II diabetes and obesity.

REFERENCES:
patent: 2407309 (1946-09-01), Lott et al.
patent: 3033870 (1962-05-01), Druey et al.
patent: 3034955 (1962-05-01), Frick et al.
patent: 3674843 (1972-07-01), Shen et al.
patent: 3686192 (1972-08-01), Moore et al.
patent: 4003734 (1977-01-01), Johnston
patent: 4013621 (1977-03-01), Knell
patent: 4061642 (1977-12-01), Fleckenstein et al.
patent: 4218237 (1980-08-01), Nishiyama et al.
patent: 4248619 (1981-02-01), Serban et al.
patent: 4289876 (1981-09-01), Algieri et al.
patent: 4499304 (1985-02-01), Gabrielsen et al.
patent: 4549901 (1985-10-01), James
patent: 4565568 (1986-01-01), Johnston et al.
patent: 4577028 (1986-03-01), Martin et al.
patent: 4670045 (1987-06-01), Ehr et al.
patent: 4731090 (1988-03-01), Boger et al.
patent: 4756739 (1988-07-01), Fuss et al.
patent: 4851419 (1989-07-01), Cox et al.
patent: 4866079 (1989-09-01), Boger et al.
patent: 4900751 (1990-02-01), Cox et al.
patent: 4946854 (1990-08-01), Maienfisch et al.
patent: 4952235 (1990-08-01), Andree et al.
patent: 4987141 (1991-01-01), Bushell et al.
patent: 5008276 (1991-04-01), Clough et al.
patent: 5070096 (1991-12-01), Mohrs et al.
patent: 5093340 (1992-03-01), Mohrs et al.
patent: 5143937 (1992-09-01), Lang et al.
patent: 5151428 (1992-09-01), Sakamoto et al.
patent: 5202336 (1993-04-01), Mohrs et al.
patent: 5204354 (1993-04-01), Chakravarty et al.
patent: 5250549 (1993-10-01), Yoshino et al.
patent: 5304532 (1994-04-01), Munro et al.
patent: 5360810 (1994-11-01), Hayase et al.
patent: 5444036 (1995-08-01), Iwasaki et al.
patent: 5514696 (1996-05-01), Murugesan et al.
patent: 5545669 (1996-08-01), Adams et al.
patent: 5610320 (1997-03-01), Yoshino et al.
patent: 5624937 (1997-04-01), Reel et al.
patent: 5643914 (1997-07-01), Daines
patent: 5684195 (1997-11-01), Huang et al.
patent: 5716993 (1998-02-01), Ozaki et al.
patent: 5780483 (1998-07-01), Widdowson et al.
patent: 5814646 (1998-09-01), Heinz et al.
patent: 5880136 (1999-03-01), Duggan et al.
patent: 5990126 (1999-11-01), Park et al.
patent: 6022897 (2000-02-01), Evans et al.
patent: 6028052 (2000-02-01), Heyman et al.
patent: 6200995 (2001-03-01), De La Brouse-Elwood et al.
patent: 6214850 (2001-04-01), Evans et al.
patent: 6262112 (2001-07-01), Mittendorf et al.
patent: 6294559 (2001-09-01), Smith
patent: 6348474 (2002-02-01), Kayakiri et al.
patent: 6353011 (2002-03-01), Pershadsingh et al.
patent: 6369075 (2002-04-01), Ruggeri et al.
patent: 6403607 (2002-06-01), Hidaka et al.
patent: 6469054 (2002-10-01), Mittendorf et al.
patent: 6545050 (2003-04-01), Mittendorf et al.
patent: 6583157 (2003-06-01), McGee et al.
patent: 6586475 (2003-07-01), Kato et al.
patent: 6620827 (2003-09-01), De la Brouse-Elwood et al.
patent: 6653309 (2003-11-01), Saunders et al.
patent: 2001/0027200 (2001-10-01), de la Brouse-Elwood et al.
patent: 2002/0037928 (2002-03-01), Jaen et al.
patent: 2003/0139390 (2003-07-01), McGee et al.
patent: 2004/0048891 (2004-03-01), Kato et al.
patent: 592 411 (1977-10-01), None
patent: 592 A11 (1977-10-01), None
patent: 36 32 329 (1988-03-01), None
patent: 3632329 (1988-03-01), None
patent: 0 069 585 (1983-01-01), None
patent: 0 148 730 (1985-07-01), None
patent: 0 261 539 (1987-09-01), None
patent: 0 261 539 (1988-03-01), None
patent: 0 306 222 (1989-03-01), None
patent: 0 778 267 (1996-11-01), None
patent: 0 749 751 (1996-12-01), None
patent: 0 472 053 (1998-06-01), None
patent: 0 855 391 (1998-07-01), None
patent: 55-79369 (1980-06-01), None
patent: 64-6245 (1989-01-01), None
patent: 9-255656 (1997-09-01), None
patent: WO 95/01326 (1995-01-01), None
patent: WO 95/01326 (1995-01-01), None
patent: WO 95/33461 (1995-12-01), None
patent: WO9533462 (1995-12-01), None
patent: WO 96/09294 (1996-03-01), None
patent: WO 96/15118 (1996-05-01), None
patent: WO 97 00857 (1997-01-01), None
patent: WO 97/30677 (1997-08-01), None
patent: WO 97/30677 (1997-08-01), None
patent: WO97/00857 (1997-09-01), None
patent: WO 97/31907 (1997-09-01), None
patent: WO 97/31907 (1997-09-01), None
patent: WO 97/36579 (1997-10-01), None
patent: WO 9736579 (1997-10-01), None
patent: WO 98/02437 (1998-01-01), None
patent: WO 98/27081 (1998-06-01), None
patent: WO 98/50029 (1998-11-01), None
patent: WO 98/50030 (1998-11-01), None
patent: WO 99/06378 (1999-02-01), None
patent: WO 99/10320 (1999-03-01), None
patent: WO 99/38845 (1999-08-01), None
patent: WO 99/50237 (1999-10-01), None
patent: WO 99/55663 (1999-11-01), None
patent: WO 00/12073 (2000-03-01), None
patent: WO 00/12623 (2000-03-01), None
patent: WO 00/17202 (2000-03-01), None
patent: WO 01/30343 (2001-05-01), None
U.S. Appl. No. 09/606,433, filed Jun. 28, 2002, McGee et al.
U.S. Appl. No. 10/456,932, filed Jun. 5, 2003, Jaen et al.
U.S. Appl. No. 10/278,851, filed Oct. 21, 2002, McGee et al.
U.S. Appl. No. 60/141,672, filed Jun. 30, 1999, McGee et al.
U.S. Appl. No. 60/201,613, filed May 3, 2000, Jaen et al.
Baguley et al., Database accession No. 108:179602. Database Chemabs ′Online!, RN 106831-10-1 CAPLUS, Eur. J. Cancer Clin. Oncol., 24(2):205-210 (1988).
Burmistrov et al., Database accession No. 115:8165, Database Chemabs ′Online!, RNs 98187-76-9 CAPLUS, 134284-40-5 CAPLUS, Zh. Org. Khim, 26(9):1995-1998 (1990).
Burmistrov et al., Database accession No. 122:132338, Database Chemabs ′Online!, RN 134284-40-5 CAPLUS, Zh. Org. Khim, 30(5):744-747 (1994).
Cain et al., “Potential antitumor agents. 14. Acridylmethanesulfonanilides,” J. Med. Chem. 17(9):922-930 (1974).
Chaturvedi et al., “Antibacterial studies of 7-(α-substituted sulfonamido)methyl- and 7-(α-substituted sulfonamido)phenyl-8-hydroxyquinolines,” Journal of the Indian Chemical Society 61(2):175-176 (1984) (Abstract. Chem. Abstract Accession No. 101:87311).
Collins et al., “N-(2-Benzoylphenyl)-L-tyrosine PPARγ agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety,” J. Med. Chem. 41(25):5037-5054 (1998).
Denny et al., Database accession No. 96:79437, Database Chemabs ′Online!, RNs 80260-24-8 CAPLUS, 80260-26-0 CAPLUS, J. Med. Chem., 25(3):276-315 (1982).
Dumas et al., “Synthesis and structure-activity relationships of novel small molecule cathepsin D inhibitors,” Bioorg. Med. Chem. Lett. 9(17):2531-2536 (1999) (Abstract. Chem. Abstract Accession No. 131:336969).
Forman et al., “15-Deoxy-Δ12, 14-Prostaglandin J2Is a Ligand for the Adipocyte Determination Factor PPARγ,” Cell, 83:803-812 (1995).
Jiang et al., “PPAR-γ agonists inhibit production of monocyte inflammatory cytokines,” Nature 391:82-86 (1998).
Lehmann et al., “Peroxisome Proliferator-activated Receptors α and γ Are Activated by Indomethacin and Other Non-steroidal Anti-inflammatory Drugs,” The Journal of Biological Chemistry, 272(6):3406-3410 (1997).
Lehamm, J., et al., “An Antidiabetic Thiazolidinedione is a High Affinity Ligand for Peroxisome Proliferator-activated Receptor γ (PPARγ)*,” J. Bio. Chem. 270(22): 12953-12956 (1995).
Mysyk et al., Database accession No. 92:163637, Database Chemabs ′Online!, RN 73320-75-9 CAPLUS, Zh. Org. Khim. 15(12):2499-2502 (1979).
Pieper et al., Database accession No. 112:138679, Database Chemabs ′Online!, RN 101513-48-8 CAPLUS, Arzneim.-Forsch., 39(9):1073-1080 (1989).
Ricote et al., “The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation,” Nature 391:79-82 (1998).
Sarul, et al., Database accession No. 103:123106, Database Chemabs ′Online!, RN 98187-77-0 CAPLUS, Latv. Psr Zinat. Akad. Vestis, Kim. Ser., 2:225-228 (1985).
Sebe et al., Database accession No. 117:214517, Database Chemabs ′Online!, RNs 144206-02-0 CAPLUS, 144232-65-5 CAPLUS, Rev. Chim, 43(5-6):222-225 (1992).
Spiegelman, B.M., “PPAR-γ: adipogenic regulator and th

Affiliated with

Also associated with

Rating

PPARγ modulators does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with PPARγ modulators, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PPARγ modulators will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3994998